Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff

[cafead]

via By the end of 2023, Novartis plans to shutter its Sandoz oral solid dosage plant in Wilson, North Carolina, where the company’s soon-to-be-spun-off generics division makes products such as tablets and capsules for Canada and the U.S. The site’s roughly 246 employees have already been alerted to the closure, a Novartis spokesperson said over email.

article source